Canaccord Genuity Maintains a 'Buy' on AMD (AMD); Cutting PT and Estimates; No One Immune From PC Weakness

Go back to Canaccord Genuity Maintains a 'Buy' on AMD (AMD); Cutting PT and Estimates; No One Immune From PC Weakness